Pharmaceutical firms moving to sell OTC drugs

Published: 2011-10-20 06:56:00

Updated: 2011-10-20 06:56:00

Korean drug makers are seeking a breakthrough in their sluggish ethical sector by entering the promising over-the-counter (OTC) market that will bring greater revenue, under the government’s shake-up in the pharmaceutical sector that will result in average drug price cuts of 17 percent starting i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK